Gotham Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$898K	Buy	40,358 +21,917	+119%	+$524K	﹤0.01%	1342
2025 Q4	$493K	Sell	18,441 -24,726	-57%	-$591K	﹤0.01%	1443
2025 Q3	$921K	Buy	43,167 +25,560	+145%	+$604K	﹤0.01%	1224
2025 Q2	$380K	Sell	17,607 -16,467	-48%	-$306K	﹤0.01%	1397
2025 Q1	$566K	Sell	34,074 -35,892	-51%	-$652K	﹤0.01%	1198
2024 Q4	$1.28M	Buy	69,966 +34,240	+96%	+$553K	0.01%	839
2024 Q3	$549K	Buy	35,726 +5,129	+17%	+$85.6K	0.01%	1079
2024 Q2	$497K	Buy	+30,597	New	+$494K	0.01%	1084
2020 Q2	–	Sell	-6,975	Closed	-$295K	–	1045
2020 Q1	$295K	Sell	6,975 -8,683	-55%	-$358K	0.01%	843
2019 Q4	$670K	Sell	15,658 -12,364	-44%	-$538K	0.01%	718
2019 Q3	$1.01M	Buy	+28,022	New	+$850K	0.02%	592
2017 Q4	–	Sell	-38,843	Closed	-$1.46M	–	921
2017 Q3	$1.46M	Buy	+38,843	New	+$1.26M	0.02%	559
2017 Q1	–	Sell	-25,682	Closed	-$741K	–	977
2016 Q4	$741K	Buy	+25,682	New	+$679K	0.01%	675